Investors at Meeting on the Mesa 2026
46 investors are at Meeting on the Mesa 2026 — 8 presentations on the program. Most represented: OrbiMed (2 on the program), Delin Ventures (1 on the program), Gordon MD Global Investments (1 on the program). 8 of them have their own page in this guide.
Focus area
Top represented
Showing 1–19 of 46 organizations
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Sumitomo Corporation Tokyo, Japan | ◆Gold Sponsor |
Invests in and operates businesses across healthcare, pharmaceuticals, infrastructure, finance, and other industries. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
OrbiMed New York, NY | |
Invests in healthcare and life sciences companies through venture capital, private equity, public equity, and royalty financing. | Panel Wed, Oct 7 9:00am Chair Wed, Oct 7 11:45am |
Delin Ventures London, United Kingdom | |
Invests in and builds early-stage cell therapy companies and related life-sciences infrastructure, alongside technology startups. | Workshop Wed, Oct 7 8:00am |
Gordon MD Global Investments Beverly Hills, CA | |
Manages private and public funds investing in biopharmaceutical companies across the United States, Europe and Japan. | |
Jennison New York, NY | |
Investment manager offering active equity and fixed-income strategies to institutional clients. | |
Novo Holdings Copenhagen, Denmark | |
Invests in life science companies and manages the Novo Nordisk Foundation’s assets across public and private markets. | |
RTW Funds New York, NY | |
Invests in life-sciences and biotechnology companies across venture, growth, crossover and public markets. | Chair Wed, Oct 7 11:45am |
Samsara Biocapital Palo Alto, CA | |
Invests in biotechnology companies developing transformative therapeutics. | |
28 Capital Boston, MA | |
Life sciences venture fund that forms and invests in early-stage biotech and therapeutic companies. | Attending On the meeting’s published attendee list |
4BIO Capital London, United Kingdom | |
Venture capital firm investing in early-stage companies developing cell, gene, RNA and other advanced therapies. | Attending On the meeting’s published attendee list |
6C 683 Capital New York, NY | |
Investment manager running pooled funds and taking positions in publicly traded companies, including biotechnology firms. | Attending On the meeting’s published attendee list |
AO Alpha Omega Investment & Development | |
Attending On the meeting’s published attendee list | |
Altaris New York, NY | |
Healthcare investment firm that acquires and builds companies across healthcare subsectors. | Attending On the meeting’s published attendee list |
Altius Bioventures Capital North Vancouver, Canada | |
Invests in and co-builds early-stage companies developing tools and technologies for advanced therapy manufacturing, testing and logistics. | Attending On the meeting’s published attendee list |
ARCH Venture Partners Chicago, IL | |
Invests in and helps build early-stage life science and technology companies from scientific discoveries. | Attending On the meeting’s published attendee list |
Avant Bio New York, NY | |
Invests in life science, healthtech and therapeutic-enabling technology companies. | Attending On the meeting’s published attendee list |
Avego Management Alpharetta, GA | |
Invests in healthcare and biotech companies through growth capital and other investment strategies. | Attending On the meeting’s published attendee list |
Balyasny Asset Management Chicago, IL | |
Multi-strategy asset manager investing across public and private markets for institutional and other investors. | Attending On the meeting’s published attendee list |
BroadOak Washington, DC | |
Invests growth capital and provides investment banking services to life sciences tools, diagnostics, and biopharma services companies. | Attending On the meeting’s published attendee list |
Instantly find 20 buyers from investors
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Meeting on the Mesa 2026 by
Organization type
Focus area
Everyone
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction